Condition

Early Stage Non-small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung CancerNCT05785845 · 2023-04-10

COMPLETED

Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLCNCT04530227 · 2020-09-25

UNKNOWN

CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung CancerNCT03916367 · 2010-12-15

COMPLETED

Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational TrialNCT01138722 · 2010-05-01

TERMINATED

Common interventions

Biological: CamrelizumabDRUG1Computed tomography-guided stereotactic adaptive radiotherapyRADIATION1CT-guided Radioactive I-125 Seeds ImplantationRADIATION1ETHOSDEVICE1hypofractionated radiation therapy followed by surgeryRADIATION1Nab-paclitaxelDRUG1PemetrexedDRUG1

Leading sponsors

Peking University Third Hospital1Tianjin Medical University Cancer Institute and Hospital1University Hospital, Ghent1Washington University School of Medicine1

Trial status mix

COMPLETED2

TERMINATED1

UNKNOWN1

Phase mix

PHASE22

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.